FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new indanone derivatives which may be preferentially used for treating and/or preventing a medical state for which cholinesterase inhibition is desired.
EFFECT: there are presented the new indanone derivatives which may be preferentially used for treating and/or preventing a medical state for which cholinesterase inhibition is desired.
11 cl, 36 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING, METHODS OF USING AND COMPOSITION OF CYCLOALKYLMETHYLAMINES | 2007 |
|
RU2462451C2 |
| COMPOSITIONS, SYNTHESIS AND METHOD FOR USING ATYPICAL ANTIPSYCHOTIC DRUGS OF QUINOLINE | 2008 |
|
RU2497819C2 |
| COMPOSITIONS, SYNTHESIS AND METHODS OF APPLYING ARYLPIPERAZINE DERIVATIVES | 2010 |
|
RU2506262C2 |
| COMPOSITIONS, SYNTHESIS AND METHODS FOR APPLICATION OF PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES | 2012 |
|
RU2642074C2 |
| LEVODOP PRODRUGS, BASED ON THEM COMPOSITIONS AND THEIR APPLICATION | 2005 |
|
RU2365580C2 |
| N4-PHENYLQUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS RECEPTOR TYROSINE KINASE TYPE ERBB INIHIBITORS FOR TREATING HYPERPROLIFERATIVE DISEASES | 2006 |
|
RU2428421C2 |
| PYRIDOPYRAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING OR PREVENTING PHYSIOLOGICAL AND/OR PATHOPHYSIOLOGICAL CONDITIONS BY INHIBITION OF ENZYMES ERK, ERK1, ERK2, PI3K, PI3Kalpha, PI3Kbeta, PI3Kgamma, PI3Kdelta, PI3K-C2alpha, PI3K-C2beta, PI3K-Vps34p (VERSIONS) | 2006 |
|
RU2515944C9 |
| COMPOUNDS AND METHODS FOR TREATING LEUKEMIA | 2013 |
|
RU2672553C2 |
| NOVEL HETEROCYCLIC COMPOUNDS AS BRD4 INHIBITORS | 2016 |
|
RU2721120C2 |
| INHIBITORS OF TYPE ErbB INHIBITORS | 2006 |
|
RU2592703C9 |
